BioDlink is a startup based in China, most recent round Pre-ipo.
Based in China, BioDlink is a startup. Its most recent tracked round is Pre-ipo.
BioDlink is a contract development and manufacturing organization (CDMO) based in Suzhou, China, specializing in the development and commercial GMP manufacturing of biological drugs including monoclonal antibodies and antibody-drug conjugates (ADCs).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.